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Is Carotid Intima-Media Thickness Useful in Cardiovascular
Disease Risk Assessment?
The Rotterdam Study
Antonio Iglesias del Sol, MD; Karel G.M. Moons, MD, PhD; Monika Hollander, MD;
Albert Hofman, MD, PhD; Peter J. Koudstaal, MD, PhD; Diederick E. Grobbee, MD, PhD;
Monique M.B. Breteler, MD, PhD; Jacqueline C.M. Witteman, PhD; Michiel L. Bots, MD, PhD
Background and Purpose—We determined the contribution of common carotid intima-media thickness (IMT) in the
prediction of future coronary heart disease and cerebrovascular disease when added to established risk factors.
Methods—We used data from a nested case-control study comprising 374 subjects with either an incident stroke or a
myocardial infarction and 1496 controls. All subjects were aged 55 years and older and participated in the Rotterdam
Study. Mean follow-up was 4.2 years (range, 0.1 to 6.5 years). We evaluated which correlates of coronary heart disease
and cerebrovascular disease contribute to the prediction of either a new incident myocardial infarction or a stroke.
Logistic regression modeling and the area under the receiver operating characteristic curve (ROC area) were used to
quantify the predictive value of the established risk factors and the added value of IMT.
Results—The ROC area of a model with age and sex only was 0.65 (95% CI, 0.62 to 0.69). Independent risk factors were
previous myocardial infarction and stroke, diabetes mellitus, smoking, systolic blood pressure, diastolic blood pressure,
and total and HDL cholesterol levels. These risk factors increased the ROC area from 0.65 to 0.72 (95% CI, 0.69 to
0.75). This model correctly predicted 17% of all subjects with coronary heart disease and cerebrovascular disease. When
common carotid IMT was added to the previous model, the ROC area increased to 0.75 (95% CI, 0.72 to 0.78). When
only the IMT measurement was used, the ROC area was 0.71 (95% CI, 0.68 to 0.74), and 14% of all subjects were
correctly predicted. There was no difference in ROC area when different measurement sites were used.
Conclusions—Adding IMT to a risk function for coronary heart disease and cerebrovascular disease does not result in a
substantial increase in the predictive value when used as a screening tool. (Stroke. 2001;32:1532-1538.)
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Carotid intima-media thickness (IMT) measurements arebeing applied widely as a measure of atherosclerosis in
studies on determinants of presence and progression of
atherosclerosis and in studies on atherosclerosis as determi-
nant of cardiovascular disease.1–4 Carotid IMT has been
shown to be related to cardiovascular risk factors, prevalent
cardiovascular disease, and atherosclerosis in the peripheral,
coronary, and femoral arteries. Recently, evidence became
available indicating that an increased carotid IMT is a strong
predictor of coronary heart disease and stroke.1,4–7 Therefore,
it has been suggested that measurements of carotid IMT may
be used to identify high-risk subjects.8
The objective of the present study is to evaluate, in elderly
subjects of the general population, which established risk
factors, such as medical history, blood pressure, and serum
lipids, are independent predictors of coronary heart disease
and cerebrovascular disease and whether measurement of
carotid IMT contributes to the prediction of coronary heart
disease and cerebrovascular disease when added to these risk
factors. Eventually, we evaluated the predictive ability of the
carotid IMT measurement alone when used to replace estab-
lished risk factors.
Subjects and Methods
Population
The Rotterdam Study is a single-center, prospective follow-up study
on disease and disability in the elderly in 7983 subjects, aged 55
years or older, living in the suburb of Ommoord in Rotterdam,
Netherlands, as detailed elsewhere.9 Baseline data were collected
from March 1990 to July 1993 during a home interview and 2 visits
at the research center. The overall participation rate of those invited
for the study was 78%. The study has been approved by the Medical
Ethics Committee of Erasmus University, and written informed
consent was obtained from all participants.
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Cerebrovascular and Cardiovascular
Risk Indicators
At baseline, information about the medical history of myocardial
infarction and stroke, current medication, alcohol intake, and smok-
ing habits was obtained by a trained research assistant. At the study
center an extensive physical examination was performed, including
height and weight measurement, 2 blood pressure measurements
(taken with a random zero sphygmomanometer with the subject in
sitting position, and averaged), a 12-lead ECG, serum total choles-
terol and HDL cholesterol levels, and a nonfasting or postload
glucose level.
Presence of hypertension was defined as a systolic pressure
$160 mm Hg or a diastolic pressure $95 mm Hg or current use of
blood pressure–lowering drugs for the indication of hypertension.
Diabetes mellitus was considered present when subjects currently
used oral blood glucose–lowering drugs or insulin or had a nonfast-
ing or postload glucose level .11 mmol/L, assessed after a nonfast-
ing venipuncture.
Incident Cerebrovascular and
Cardiovascular Disease
Information on incident fatal and nonfatal events is obtained from the
general practitioners working in the district of Ommoord. The
general practitioners report all possible cases of myocardial infarc-
tion and stroke to the Rotterdam research center. Events are coded
according to the International Classification of Primary Care.10
Information on the vital status of the participants is obtained at
regular intervals from the municipal authorities in Rotterdam. When
an event or death has been reported, additional information is
obtained by scrutinizing information from general practitioner and
hospital discharge records in case of admittance or referral. Events
are then confirmed by 2 study physicians. Additionally, all data
about new cases of myocardial infarction were reviewed by a
cardiologist, and all data about stroke cases were reviewed by a
neurologist; neither physician actually saw the patient. In case of
disagreement, consensus was reached in additional meetings. An
incident myocardial infarction was considered to have occurred
when the event led to a hospitalization and the hospital discharge
record indicated a diagnosis of a new myocardial infarction on the
basis of signs and symptoms, ECG recordings, and repeated labora-
tory investigations during hospital stay. All suspected cerebrovascu-
lar events reported by the general practitioners were submitted for
review to a neurologist (P.J.K.). The neurologist classified the events
as definite, probable, and possible stroke on the basis of all
information, including symptoms and signs obtained by interviewing
the general practitioner or, in case of hospital referral, hospital data.
An incident stroke was considered to have occurred when (1) the
event had led to a hospitalization and the hospital discharge record
indicated a diagnosis of a new stroke; the clinical diagnosis was
based on signs, symptoms, and neuroimaging investigations during
hospital stay; or (2) in case of no hospitalization, signs and
symptoms associated with the event obtained from the general
practitioner were highly suggestive of a stroke according to the
neurologist (probable stroke); or (3) in case of out-of-hospital death,
when the general practitioner reported that the cause of death was a
cerebrovascular accident and a cardiac cause was judged to be highly
unlikely. For the analyses, only definite and probable incident
strokes were included.
Measurement of IMT
To measure carotid IMT, ultrasonography of the common carotid
artery (CCA), carotid bifurcation, and internal carotid artery (ICA) of
the left and right carotid arteries was performed with a 7.5-MHz
linear-array transducer (ATL Ultra-Mark IV). On a longitudinal,
2-dimensional ultrasound image of the carotid artery, the anterior
(near) and posterior (far) walls of the carotid artery are displayed as
2 bright white lines separated by a hypoechogenic space. The
distance between the leading edge of the first bright line of the far
wall and the leading edge of the second bright line indicates the IMT.
For the near wall, the distance between the trailing edge of the first
bright line and the trailing edge of the second bright line at the near
wall provides the best estimate of the near wall IMT.11 In accordance
with the Rotterdam Study ultrasound protocol,12 a careful search was
performed to obtain the optimal representation of both the near and
far walls of the distal CCA, the carotid bifurcation, and the ICA.
When an optimal longitudinal image was obtained, it was frozen on
the R wave of the ECG and stored on videotape. The actual
measurements of IMT were performed offline. From videotape, the
frozen images were digitized on the screen of a personal computer
with the use of additional dedicated software. This procedure has
been described in detail previously.13,14 In short, with a cursor, or
automatically by the computer, the interfaces of the CCA were
marked across a length of 10 mm. The computer then calculated the
mean IMT and the maximum IMT over the marked length for both
near and far walls. We used the average of the measurements of 3
frozen images of both the left and right arteries to obtain mean values
of the mean and the maximum thickness for each subject. For the
carotid bifurcation and the ICA, the interfaces were marked across a
variable length at the thickest part of the measurement site. Then the
maximum IMT was calculated over the marked length. For the
analyses, the maximum carotid IMT was determined as the mean of
the maximum IMT of near and far wall measurements of both the left
and right arteries. A composite measure that combined the maximal
CCA IMT, the maximal bifurcation IMT, and the maximal ICA IMT,
when available, was obtained by averaging the 3 measurements after
standardization (subject maximum IMT minus cohort mean of the
maximum IMT, divided by cohort SD of the maximum IMT). The
readers of the ultrasound images were unaware of the case status of
the subject. Results from a reproducibility study of IMT measure-
ments of the CCA among 80 participants of the Rotterdam Study
who underwent a second ultrasound of both carotid arteries within 3
months of the first scan have been described elsewhere.15 In short,
mean differences (SD) in far wall IMT of the CCA between paired
measurements of sonographers, readers, and visits were 0.005 (0.09),
0.060 (0.05), and 0.033 mm (0.12), respectively. Corresponding
intraclass correlation coefficients were 0.63, 0.88, and 0.74,
respectively.
Selection of Cases and Controls
Ultrasonography of the carotid arteries was performed in 5965 of the
7983 subjects in the Rotterdam Study. For subjects who had their
baseline examination at the end of 1992 and in 1993, ultrasonogra-
phy could not always be performed because of the restricted
availability of ultrasonographers. Since this may be considered a
random sample, for the present study the cases and controls were
drawn from this cohort of 5965 subjects. For reasons of availability
and completeness of information on coronary heart and cerebrovas-
cular events, we restricted the present study to follow-up events
registered by general practitioners before May 1996. The mean
duration of follow-up was 4.2 years (range, 0.1 to 6.5 years; SD, 1.6).
We selected 374 case subjects with incident coronary heart disease
and cerebrovascular disease, of whom 194 subjects had a myocardial
infarction and 191 subjects had a stroke (11 subjects had both a
myocardial infarction and a stroke, for which we used the event that
occurred first). For these subjects, data on carotid IMT were obtained
from the stored images on videotape. For each case subject, 4 control
subjects were drawn. A subject was eligible as a control if he/she was
free from myocardial infarction and stroke. The total number of
control subjects was 1496, resulting in a total number of 1870
subjects.
Data Analysis
First, data analysis was separately performed for the 2 outcomes
(myocardial infarction and stroke) with the same control group. Only
subjects with complete data on all risk factors and CCA IMT
measurement were included, resulting in a data set of 1721 subjects:
328 cases (174 myocardial infarctions and 165 strokes; 11 had both)
and 1393 controls. The association between each risk factor and
myocardial infarction was quantified by logistic regression analyses,
with adjustment for age and sex. The odds ratio (OR) and 95% CI
were used as measure of association. Variables associated with
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myocardial infarction (P,0.10) were then included in a multivariate
logistic regression model to evaluate the independent contribution in
the prediction of myocardial infarction. The first (overall) model
included all “univariately” (ie, age and sex adjusted) significant
variables from medical history and physical examination. Model
reduction was performed by excluding variables that were not
significantly related with myocardial infarction (OR with P,0.10)
from the overall model. Subsequently, the reduced model was
extended with carotid IMT measurements to evaluate their added
value in the prediction of myocardial infarction. Differences in
predictive value between all different prediction models (overall,
reduced, and extended) were estimated by comparison of the area
under the receiver operating characteristic curve (ROC area) with
standard error.16,17 The ROC curve of a multivariate logistic model
plots the sensitivity and 12specificity at each consecutive threshold
in the range of predicted probabilities of the model. The ROC area is
a measure of the discriminative or predictive ability of the model that
can range from 0.5 (no discrimination between subjects with and
without myocardial infarction) to 1.0 (perfect discrimination). In all
model comparisons, correlation between the models was taken into
account because they were based on the same cases.18
The ROC area reflects the overall added value of a model and does
not directly indicate its clinical value.19,20 Therefore, we additionally
estimated for the final model the absolute number of correctly
predicted patients with and without myocardial infarction. A similar
analytical approach was followed for stroke as outcome and for the
combined coronary heart disease and cerebrovascular disease out-
come (both myocardial infarction and stroke).
A different analysis was performed to evaluate any differences in
the predictive value for total coronary heart disease and cerebrovas-
cular disease (ie, myocardial infarction or stroke) between 3 IMT
measurement sites and the combined IMT measure with the use of
logistic regression analyses in combination with ROC curves. This
analysis was done on a restricted data set with complete data for all
3 measurement sites, resulting in a data set of 512 subjects: 156 cases
(74 myocardial infarctions and 74 strokes; 8 subjects had both) and
356 controls. Data on IMT at the carotid bifurcation were available
in 64% of the 1870 subjects (74% of all myocardial infarction and
stroke cases and 61% of controls); data on IMT of the ICA were
available in 31% (47% of all cases and 27% of controls); and data on
IMT of the CCA were available in 96% (92% of all cases and 97%
of controls).
All analyses were performed with the use of SPSS software,
version 9.0 (SPSS Inc).
Results
The general characteristics of the study population are given
in Table 1. The age- and sex-adjusted associations for all
evaluated risk indicators, including the carotid IMT measure-
ments, with myocardial infarction and stroke are given in
Table 2. Although the magnitude of the association of each
variable with both coronary heart disease and cerebrovascular
disease outcomes was different, the same predictors were of
importance for both outcomes. Age, male sex, smoking,
systolic blood pressure, hypertension, total cholesterol, HDL
cholesterol, previous myocardial infarction, previous stroke,
and carotid IMT measurements were highly associated with
myocardial infarction. For stroke, diastolic blood pressure
was also a predictor, while total and HDL cholesterol and
diabetes mellitus were much less important predictors.
Table 3 shows, for outcomes of both myocardial infarction
and stroke, the ORs of the independent predictors in 2
predictive models. Model 1 has the independent predictors
added, such as previous coronary heart disease and cerebro-
vascular disease, diabetes mellitus, smoking, systolic and
diastolic blood pressure, and total and HDL cholesterol.
Model 2 is the same model extended with the CCA IMT. For
both outcomes almost the same independent predictors were
found, except for blood lipids, which were not independent
predictors of stroke. In the prediction of myocardial infarc-
tion, the ROC area of model 1 was 0.75 (95% CI, 0.72 to
0.79), whereas for the prediction of stroke it was 0.73 (95%
CI, 0.69 to 0.77). Because for both outcomes the independent
predictors were virtually the same and the ROC areas were
also similar, we decided to combine myocardial infarction
and stroke as one combined coronary heart disease and
cerebrovascular disease outcome. For the prediction of this
combined outcome, a model with age and sex only reached a
ROC area of 0.65 (95% CI, 0.62 to 0.69). The ROC area of
model 1 (Table 3) increased significantly (P50.01) from 0.65
to 0.72 (95% CI, 0.69 to 0.75). When CCA IMT was added
to model 1 (Table 3) for the prediction of the combined
outcome (model 2), there was a significant increase (P50.01)
from 0.72 to 0.75 (95% CI, 0.72 to 0.78). When model 3, a
model with age, sex, and CCA IMT only, was used instead of
model 2, the ROC area increased (P50.01) from 0.65 to 0.71
(95% CI, 0.68 to 0.74).
In a subgroup analysis on 512 subjects (156 cases and 356
controls), we then evaluated the added contribution of each of
the 4 IMT measurements in the prediction of the combined
outcome by separately adding them to model 1 (Table 4). In
this subset the ROC area of model 1 was 0.72 (95% CI, 0.67
to 0.77). This was increased (P50.07) to 0.74 (95% CI, 0.69
to 0.78) when CCA IMT was added to model 1, to 0.74 (95%
CI, 0.69 to 0.78) (P50.07) when bifurcation IMT was added,
to 0.75 (95% CI, 0.70 to 0.79) (P50.01) when ICA IMT was
added, and to 0.75 (95% CI, 0.71 to 0.80) when the combined
IMT measurement was added. The CCA IMT was used for
the remainder of the analyses because the increase in ROC
TABLE 1. Baseline Characteristics of the Study Population
Characteristic
Myocardial
Infarction Stroke
Control
Subjects
n 194 191 1496
Age, y 72* 75* 70
Female, % 39* 54* 62
Body mass index, kg/m2 26.3 (3.4) 26.4 (3.9) 26.6 (3.8)
Current smoking, % 30 28 22
Systolic blood pressure, mm Hg 144 (22.5)* 149 (24.0)* 138 (21.3)
Diastolic blood pressure, mm Hg 72 (12.3) 75 (13.4)* 72 (10.9)
Hypertension, % 41* 52* 34
Total cholesterol, mol/L 6.9 (1.2)* 6.5 (1.2) 6.7 (1.3)
HDL cholesterol, mmol/L 120 (0.28)* 1.31 (0.38) 1.34 (0.38)
Diabetes mellitus, % 13* 14* 7
Previous myocardial infarction, % 31* 23* 12
Previous stroke, % 6 11* 2
Maximum CCA IMT, mm 1.17 (0.29)* 1.22 (0.35)* 1.02 (0.21)
Maximum bifurcation IMT, mm 1.76 (0.68)* 1.83 (0.73)* 1.44 (0.59)
Maximum ICA IMT, mm 1.42 (0.61)* 1.62 (0.81)* 1.15 (0.62)
Values are unadjusted proportions or means, with SD in parentheses.
*P,0.05 compared with control subjects, adjusted for differences in age
and sex.
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area for the different sites did not differ substantially and
because it was available for 95% of all 1870 subjects.
To evaluate the difference in predictive value between the
model with all independent predictors (model 1) and a model
with only CCA IMT added to age and sex (model 3), we
obtained an estimate of absolute incidences in the total cohort
of the combined outcome (coronary heart disease and cere-
brovascular disease) across categories of the model’s pre-
dicted probability. Initially, the absolute incidence was set by
the case-control ratio of 1:4, giving 25%. Therefore, all
TABLE 2. Association of Risk Factors With Myocardial Infarction and Stroke
Risk Factor
Myocardial Infarction
(n5194)
Stroke
(n5191)
Characteristics from medical history and
physical examination
Age (year) 1.19 (1.08–1.30) 1.45 (1.33–1.59)
Sex (female) 0.37 (0.27–0.51) 0.64 (0.47–0.89)
Previous myocardial infarction (yes/no) 2.64 (1.85–3.78) 1.61 (1.08–2.40)
Previous stroke (yes/no) 2.18 (1.07–4.46) 4.20 (2.30–7.65)
Smoking
Current smoking (yes/no) 1.80 (1.10–2.95) 1.90 (1.18–3.05)
Former smoking (yes/no) 1.44 (0.91–2.28) 1.26 (0.82–1.96)
Body mass index (kg/m2) 1.00 (0.96–1.05) 0.99 (0.95–1.04)
Systolic blood pressure (10 mm Hg) 1.10 (1.02–1.18) 1.18 (1.10–1.27)
Diastolic blood pressure (10 mm Hg) 1.00 (0.87–1.15) 1.31 (1.14–1.50)
Hypertension (yes/no) 1.11 (1.02–1.22) 1.17 (1.08–1.28)
Total cholesterol (mmol/L) 1.31 (1.16–1.49) 0.98 (0.86–1.12)
HDL cholesterol (mmol/L) 0.38 (0.22–0.64) 0.91 (0.58–1.43)
Diabetes mellitus (yes/no) 1.23 (1.03–1.46) 1.13 (0.92–1.39)
Carotid IMT measurements
Maximum CCA IMT (per SD) 1.51 (1.32–1.74) 1.56 (1.37–1.77)
Maximum bifurcation IMT (per SD) 1.44 (1.22–1.69) 1.51 (1.28–1.77)
Maximum ICA IMT (per SD) 1.27 (1.01–1.59) 1.56 (1.26–1.92)
Combined IMT 1.71 (1.45–2.01) 1.68 (1.44–1.96)
Values are ORs with 95% CIs, adjusted for age and sex (except for age and sex).
TABLE 3. Results of Multivariate Logistic Regression Analyses for Stroke, Myocardial Infarction, and
Cardiovascular/Cerebrovascular Disease and ROC Area
Risk Factor
Myocardial
Infarction
(n5194)
Stroke
(n5191)
CVD (Stroke and MI)
(n5374)
Model 1 Model 1 Model 1 Model 2
Age (per 5y) 1.16 (1.03–1.30) 1.42 (1.26–1.60) 1.28 (1.18–1.40) 1.20 (1.10–1.32)
Sex (women) 0.48 (0.32–0.73) 0.91 (0.60–1.39) 0.63 (0.46–0.85)
Previous CVD 2.40 (1.65–3.49) 1.94 (1.30–2.89) 2.27 (1.70–3.04) 2.13 (1.58–2.86)
Diabetes mellitus 1.21 (1.00–1.48) 1.15 (0.92–1.45) 1.19 (1.00–1.41) 1.22 (1.03–1.45)
Smoking*
Current 2.02 (1.18–3.45) 2.11 (1.26–3.53) 1.97 (1.34–2.89) 1.73 (1.17–2.56)
Former 1.44 (0.87–2.38) 1.35 (0.84–2.17) 1.35 (0.94–1.93) 1.29 (0.90–1.85)
Systolic blood pressure (per 10 mm Hg) 1.13 (1.02–1.25) 1.14 (1.03–1.25) 1.14 (1.06–1.23) 1.08 (1.00–1.16)
Diastolic blood pressure (per 10 mm Hg) 0.85 (0.70–1.03) 1.16 (0.97–1.38) 0.98 (0.86–1.13) 1.04 (0.90–1.20)
Total cholesterol (mmol/L) 1.34 (1.17–1.53) 0.99 (0.86–1.15) 1.15 (1.04–1.27) 1.13 (1.02–1.25)
HDL cholesterol (mmol/L) 0.36 (0.20–0.64) 0.84 (0.51–1.38) 0.57 (0.39–0.85) 0.62 (0.41–1.92)
Maximum CCA IMT (mm) 5.72 (3.40–12.6)
ROC area 0.75 (0.72–0.79) 0.73 (0.69–0.77) 0.72 (0.69–0.75) 0.75 (0.72–0.78)
CVD indicates coronary heart disease and cerebrovascular disease. Values are ORs with 95% CIs.
*Included as 2 indicator variables, with no smoking as the reference category.
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subjects in the control group were given a weight that was the
inverse of the sampling fraction. The sampling fraction was
calculated by dividing 1496 controls by the cohort of 5965
subjects minus 374 cases, giving a sampling fraction of 0.27
and a weight of 3.74. Hence, a new data set was created that
included all cases and the weighted control group resembling
the entire cohort. Table 5 shows the estimated distribution of
subjects with and without coronary heart disease and cere-
brovascular disease, across selected probability categories of
both models 1 and 3. From this table one can directly obtain
the predictive value for presence or absence of coronary heart
disease and cerebrovascular disease per probability category
(reading horizontally). For model 1, for example, of all 3048
subjects with an estimated probability #5%, 84 subjects had
coronary heart disease and cerebrovascular disease and 2964
did not, yielding a predictive value of coronary heart disease
and cerebrovascular disease presence of 84/304852.8% and
of coronary heart disease and cerebrovascular disease ab-
sence of 97.2%. Of 119 subjects with an estimated probability
$21%, 25 subjects experienced an event and 94 did not, a
predictive value of coronary heart disease and cerebrovascu-
lar disease presence of 25/119521%. For model 3, of all
3081 subjects with an estimated probability #5%, 82 subjects
experienced a coronary heart or cerebrovascular event, a
predictive value for coronary heart disease and cerebrovas-
cular disease presence of 2.4%. In the category $21%, the
predictive value for presence of coronary heart disease and
cerebrovascular disease was 20%. Table 5 also enables
estimation of the sensitivity and specificity at different
probability thresholds (reading vertically). Therefore, a
threshold probability must be used above which the proba-
bility, as estimated by the model, is considered a “positive”
test result. For example, when model 1 is used at an arbitrary
threshold probability of 15%, it can be seen that of all 308
(1891119) subjects with a $16% risk of coronary heart
disease and cerebrovascular disease, 53 (28125) indeed had
a myocardial infarction or stroke, correctly predicting 17%
(9%18%) of all coronary heart disease and cerebrovascular
disease patients (ie, the sensitivity or true positive rate), while
255 (161194) did not, so that only 5% (3%12%) of all
subjects were without coronary heart disease and cerebrovas-
cular disease (ie, 12specificity or false-positive rate), a
specificity of 95%. Using the same threshold of 15% when
using carotid IMT (model 3) showed that of all 231
(1281103) subjects with a $16% risk, 48 (27121) indeed
experienced a coronary heart or cerebrovascular event (a
sensitivity of 14%), while 183 (101182) did not, resulting in
4% false-positives and a specificity of 96%. Similarly,
sensitivity and specificity can be calculated for different
threshold probabilities.
Discussion
Despite the observation of a significant association between
carotid IMT and risk of future coronary heart disease and
cerebrovascular disease, the contribution of a single carotid
IMT measurement, which represents the average of the
maximum IMT values of the near and far walls of both left
and right carotid arteries, to estimate the risk of coronary
heart disease and cerebrovascular disease on an individual
level is small. Our study showed that clinical coronary heart
disease and cerebrovascular disease risk factors obtained with
medical history and physical examination, such as blood
pressure and cholesterol measurements, can predict the future
occurrence of coronary heart disease and cerebrovascular
disease reasonably well. Using these parameters facilitates
the early prediction of approximately 17% of all future
cardiovascular/cerebrovascular disease cases (sensitivity)
with only 5% false-positive predictions (95% specificity).
TABLE 4. Contribution of Different IMT Measures to Model 1
in the Prediction of Coronary Heart Disease and
Cerebrovascular Disease
Model ROC Area (95% CI)
Model 1 0.72 (0.67–0.77)
Model 11maximum CCA IMT 0.74 (0.69–0.78)
Model 11maximum BIF IMT 0.74 (0.69–0.78)
Model 11maximum ICA IMT 0.75 (0.70–0.79)
Model 11combined IMT 0.75 (0.71–0.80)
*BIF indicates carotid bifurcation.
TABLE 5. Distribution of Subjects With and Without Coronary Heart Disease and Cerebrovascular Disease
According to Estimated Probability (Risk) by Prognostic Models 1 and 3
Estimated
Probability*
Model 1 Model 3
CVD %† N‡ CVD1§ CVD2\ CVD %† N‡ CVD1§ CVD2\
#5% 2.8 3048 (55) 84 (26) 2964 (57) 2.7 3081 (56) 82 (25) 2999 (58)
6–10% 7.7 1688 (31) 130 (40) 1558 (30) 8.9 1759 (32) 56(48) 1603 (31)
11–15% 12.4 491 (9) 61 (19) 430 (8) 9.1 464 (8) 42 (13) 422 (8)
16–20% 14.8 189 (3) 28 (9) 161 (3) 21.1 128 (2) 27 (8) 101 (2)
$21% 21.0 119 (2) 25 (8) 94 (2) 20.4 103 (2) 21 (6) 82 (2)
Total 5535 328 5207 5535 328 5207
Values are absolute number of-subjects with percentages of the column total between parentheses, unless stated otherwise.
*Categories of estimated probability of risk, as estimated by the models.
†Actual incidence of coronary heart disease and cerebrovascular disease (CVD) per probability category.
‡Estimated number (percentage, ie, estimated incidence) of patients per probability category.
§Estimated number (percentage) of people with CVD per probability category.
\Estimated number (percentage) of people without CVD per probability category.
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Using the carotid IMT measurement was not substantially
worse in the classification of risk of future coronary heart
disease and cerebrovascular disease because sensitivity for
carotid IMT alone was 14%, while the percentage of false-
positives was only 4% (96% specificity). For these estimates
we used an arbitrary threshold probability of 15%, above
which subjects were classified as future cases of coronary
heart disease and cerebrovascular disease. Using risk thresh-
olds other than 15%, as we used, did not yield other results.
Whether using sequential measurements will be more useful
still needs to be studied.
To appreciate the results of the present analysis, some
aspects need to be discussed. First, the estimates of sensitiv-
ity, specificity, and predictive values apply to a prognostic
setting, with a low baseline risk of the disease, and should not
be confused with (the usually much higher) estimates ob-
tained from a diagnostic setting, in which the a priori chance
of having the disease under study is much higher. We showed
that established risk factors correctly classified 17% of all
subjects with coronary heart disease and cerebrovascular
disease, while the carotid IMT measurement correctly clas-
sified 14%. Thus, performing only a carotid IMT measure-
ment leads to a 3% reduction in correctly predicting the
presence of coronary heart disease and cerebrovascular dis-
ease. Although the value of carotid IMT as a proxy of
atherosclerosis in epidemiological studies is without debate,
in daily practice carotid IMT measurement is still a time- and
money-consuming investigation, which is not easily per-
formed in primary care. Therefore, its value as a screening
tool seems to be limited. Second, CCA IMT was measured
only once at baseline. Although studies indicate good repro-
ducibility, automatic edge-detection computer programs may
further reduce the measurement error as well as duplicate
measurements may. Third, the present analysis was restricted
to those 95% of all subjects with complete data on all risk
indicators and carotid IMT measurements. It is not likely that
the found associations would be different if all those with
missing data were not excluded, since there was no reason to
believe that the risk indicators and ultrasonography were
obtained from a selected sample of the study cohort. This is
further exemplified by the analyses on the restricted data set
in which the ROC areas were virtually the same. Fourth,
because of the case-control design of the present study, the
ORs (regression coefficients) of the predictors are correctly
estimated, whereas a baseline risk of coronary heart disease
and cerebrovascular disease (ie, the intercept or constant of a
model) could not be directly estimated. Therefore, we applied
a weighting procedure to the control group to obtain Table 5.
If one desires to estimate the absolute risk for subjects in a
different population, one can directly use the (adjusted)
regression coefficients (Table 3), although one must first
adjust the constant for the prevalence of coronary heart
disease and cerebrovascular disease in the population at hand.
In several studies a high carotid IMT was related to future
coronary heart and cerebrovascular events.4,5,7 Despite the
different ultrasound protocols used in these studies, the
results for the CCA IMT are remarkably similar. The OR per
SD increase in the Atherosclerosis Risk in Communities
(ARIC) Study for coronary heart disease was 1.92 (95% CI,
1.66 to 2.22) for women and 1.32 (95% CI, 1.13 to 1.54) for
men. In the Cardiovascular Health Study, the relative risk for
coronary heart disease and stroke as a combined outcome was
1.35 (95% CI, 1.25 to 1.45). In the Rotterdam Study, the ORs
were1.41 (95% CI, 1.25 to 1.82) for stroke and 1.43 (95% CI,
1.16 to 1.78) for myocardial infarction. Recently, Touboul et
al21 found, in cross-sectional analyses on data from the Étude
du Profil Génétique de l’Infarctus Cérébral (GÉNIC) study,
that an increased CCA IMT was associated with brain
infarctions, both overall and in the main subtypes. In all
studies, including the present one, the association remained
when coronary heart disease and cerebrovascular disease risk
factors were accounted for.
In conclusion, the present study indicates that a single
carotid IMT measurement is of the same importance as
commonly used risk factors in the prediction of coronary
heart disease and cerebrovascular disease. Relative to the
other easily obtainable and established risk factors, it does not
add substantially when used as a screening tool to discrimi-
nate subjects with high and low risk of coronary heart disease
and cerebrovascular disease.
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